| Literature DB >> 24311843 |
Xingjiang Mao1, Gengfu Wang, Wei Zhang, Shaoping Li.
Abstract
The objective of the study was to investigate the in-vivo anti-tumour activity of Spica prunellae extract, and to preliminarily explore the possible mechanism of in-vivo anti-tumour effect of Spica prunellae extract. Tumour inhibition rate and tumour apoptosis-related protein status were determined using the mice model of transplanted T lymphoma cell EL-4 tumour, and by immunohistochemical method. The results revealed that Spica prunellae extract showed certain tumour inhibitory effect, and compared with the model group. Tumour weight in Spica prunellae high-dose group was highly significantly different (P<0.01). Tumour weight in Spica prunellae medium-dose group was also significantly different (P<0.05) compared with the model group. Spica prunellae high-dose group enabled the high expression of Bcl-2 protein (47.54%) and low expression of Bax protein (13.14%). The study concluded that Spica prunellae extract has certain in vivo anti-tumour effect, which may be achieved through regulation of apoptosis related proteins.Entities:
Keywords: EL-4 solid tumour; Spica prunellae; mechanism; tumour inhibition
Mesh：
Substances：
Year: 2013 PMID： 24311843 PMCID： PMC3847423
Source DB: PubMed Journal: Afr J Tradit Complement Altern Med ISSN： 2505-0044